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Abstract
Background: The lack of continuity between health-related quality of life (HRQoL) instruments designed for children and
adults hinders change analysis with a life course approach. To resolve this gap, EuroQol (EQ) developed the EQ-5D-Youth
(EQ-5D-Y), derived from the EQ-5D for adults. Few studies have assessed the metric properties of EQ-5D-Y in children with
specific chronic conditions, and none have done so for children with type I diabetes mellitus (T1DM).
Objective: This study aimed to evaluate the acceptability, validity, reliability, and responsiveness of the EQ-5D-Y in children
and adolescents with T1DM, when administered online.
Methods: Participants with T1DM were consecutively recruited from July to December 2014, from a list of potential candidates
aged 8-19 years, who attended outpatient pediatric endocrinology units. Before every quarterly routine visit, participants received
an email/telephone reminder to complete the online version of two generic HRQoL questionnaires: EQ-5D-Y and KIDSCREEN-27.
The EQ-5D-Y measures five dimensions, from which an equally weighted summary score was constructed (range: 0-100).
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Completion rate and distribution statistics were calculated. Construct validity was evaluated through known group comparisons
based on general health, acute diabetic decompensations, mental health, family function, and a multitrait, multimethod matrix
between EQ-5D-Y and KIDSCREEN by using Spearman correlations. Construct validity hypotheses were stated a priori. Reliability
was assessed with the intraclass correlation coefficient and responsiveness by testing changes over time and calculating the effect
size. Reliability and responsiveness were tested among the stable and improved subsamples defined by a KIDSCREEN-10 index
change of <4.5 points or ≥4.5 points, respectively, from the first to the fourth visit.
Results: Of the 136 participants, 119 (87.5%) responded to the EQ-5D-Y at the last visit. The dimensions that showed higher
percentages of participants with problems were “having pain/discomfort” (34.6%) and “worried/sad/unhappy” (28.7%). The mean
(SD) of the EQ-5D-Y summary score was 8.5 (10.9), with ceiling and floor effects of 50.7% and 0%, respectively. Statistically
significant HRQoL differences between groups defined by their general health (excellent/very good and good/regular/bad) and
mental health (Strengths and Difficulties Questionnaire score ≤15 and >16, respectively) were found in three EQ-5D-Y dimensions
(“doing usual activities,” “having pain/discomfort,” and “feeling worried/sad/unhappy”), summary score (effect size for general
health and mental health groups=0.7 and 1.5, respectively), and KIDSCREEN-10 index (effect size for general health and mental
health groups=0.6 and 0.9, respectively). Significant differences in the EQ-5D-Y dimensions were also found according to acute
diabetic decompensations in “looking after myself” (P=.005) and according to family function in “having pain/discomfort”
(P=.03). Results of the multitrait, multimethod matrix confirmed three of the four relationships hypothesized as substantial (0.21,
0.58, 0.50, and 0.46). The EQ-5D-Y summary score presented an intraclass correlation coefficient of 0.83. Statistically significant
change between visits was observed in the improved subsample, with an effect size of 0.7 (P<.001).
Conclusions: These results support the use of the EQ-5D-Y administered online as an acceptable, valid, reliable, and responsive
instrument for evaluating HRQoL in children and adolescents with T1DM.
(J Med Internet Res 2019;21(11):e14947)  doi: 10.2196/14947
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Introduction
Type 1 diabetes mellitus (T1DM) is one of the most common
chronic childhood illnesses, affecting approximately 1 in every
400-600 children and adolescents [1]. Treatment includes a
multifaceted regimen with daily subcutaneous insulin injections
(or insulin infusion), blood glucose monitoring, carbohydrate
counting, dietary plan, and physical activity [2]. Due to its
complexity, T1DM management can be overwhelming even
for the most competent patient [3]. Children might feel different
from their peers because of their need for disruptive self-care
activities [4] and the impact of T1DM on psychological aspects
[5]. Health-related quality of life (HRQoL) captures the
individual’s health perception, adding the patients’ perspective
into T1DM clinical monitoring and research.
The lack of correspondence and continuity between HRQoL
instruments designed for children and those designed for adults
hinders the analysis of HRQoL changes using a life course
approach. To solve this gap, in 2006, the EuroQol Group
developed the EQ-5D-Youth (EQ-5D-Y) as a version of the
EQ-5D for adults. The EQ-5D-Y was designed by adapting the
EQ-5D dimensions to the requirements of HRQoL measurement
in children and adolescents aged 8 years or older [6,7]. The
main rationale of the new version was to enable young
individuals to self-report their health [6,8]. A EQ-5D-Y proxy
version was also developed [9] for children below 8 years of
age. Given its generic and econometric nature, it allows
comparison between different populations and conditions, and
cost-utility analysis for economic evaluation. Another
econometric instrument, the Health Utility Index [10], has a
self-administered version for adults and adolescents and a proxy
version for children (5-12 years of age), but its administration
burden is substantially greater.
The EQ-5D-Y is a very short (2-3 minutes) and simple
instrument to fill out. There are several studies assessing the
metric properties of the EQ-5D-Y in the general population
[11,12] or in school environments [13-16]. A Swedish study
[12] suggested that the EQ-5D-Y was comprehensible,
acceptable, and feasible for self-completion. A multicountry
study supported its feasibility, reliability, and validity [11].
Furthermore, a Spanish study [16] compared the paper and
Web-based versions of EQ-5D-Y, showing acceptable levels
of agreement.
Only a few studies have assessed the metric properties of
EQ-5D-Y in children with specific chronic conditions. A
multicenter study among patients with cystic fibrosis [17]
concluded that the EQ-5D-Y can be considered a valid
instrument, which reflects the differences in health according
to the progression of this life-long chronic disease. A
comparison between the EQ-5D-Y and the Pediatric Asthma
Quality of Life Questionnaire [18] supported EQ-5D-Y’s
convergent validity for asthmatic children and adolescents. In
addition, a study in youth with chronic kidney disease provided
evidence of the EQ-5D-Y validity, as it discriminated among
groups that differed with regard to the disease-related clinical
burden [19]. Finally, we have only identified one descriptive
study of HRQoL in children with T1DM [20] measured with
the EQ-5D-Y, but without assessing its metric properties. Our
aim was to evaluate acceptability, validity, reliability and
responsiveness of the EQ-5D-Y administered online in children
and adolescents with T1DM.
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Data was obtained from a clinical trial on children and
adolescents with T1DM, designed to evaluate the impact of
routine use of HRQoL assessment in clinical practice by using
the KIDSCREEN-27 as the primary outcome. Previous
publications of this trial reported that the baseline HRQoL of
children and adolescents with T1DM [21] was similar to that
of the European population of the same age, but with slightly
worse physical well-being, and that routine assessment and
face-to-face patient-physician discussion of HRQoL results
improved after a year of follow-up, especially psychological
well-being and school environment [22].
Methods
Participants and Study Design
Subjects were consecutively recruited from July to December
2014, from a list of 205 potential candidates with T1DM, aged
between 8 and 19 years, attending outpatient pediatric
endocrinology units of 5 hospitals. Exclusion criteria were as
follows: T1DM diagnosed within the last 6 months and presence
of cognitive problems that prevented comprehension of the
questionnaires. Seven pediatricians were randomly assigned to
either the intervention or control group (four and three
pediatricians, respectively).
Families of children that fulfilled the inclusion criteria were
informed about the project, and those who agreed to participate
received a reminder by email and then by telephone, if
necessary, before every quarterly routine visit to complete the
online questionnaires within the 48 hours prior to the visit (for
children with limited access to internet, a laptop was available
at the doctor’s office).
The intervention involved a discussion of the HRQoL scores
between the doctor and the participant at each routine visit. The
KIDSCREEN-27 and EQ-5D-Y results were displayed with
different colors, similar to a traffic light, marking green for
good, yellow for medium, and red for poor outcomes.
Evolutionary results were displayed in the second, third, and
fourth visits, to show a comparison with the previous results.
At each visit, pediatricians invited the patients to comment and
discuss the results, identifying dimensions with low value scores,
exploring possible solutions and actions, and coming back to
these actions over time with advice. Before starting the study,
the pediatricians in this group had received standardized training
in the use and interpretation of HRQoL questionnaires.
The control group also completed the questionnaires online.
However, the questionnaires completed by the control group
48 h before each visit were about physical activity and diet, and
the HRQoL questionnaires were completed only before the first
and fourth visits. During the consultation, the patients received
usual care without commenting on the results of the
questionnaires (physicians did not receive any instruction on
clinical management).
Study Variables
Information collected from clinical records included age, gender,
weight, height, and glycated hemoglobin (HbA1c) levels. Acute
diabetic decompensations during the previous 3 months were
registered: hypoglycemia (<60 mg/dL) with decreased level of
consciousness, requiring glucagon or the help of others to
recover, and hyperglycemia (>400-450 mg/dL), which required
intervention of professionals or presented with diabetic
ketoacidosis.
HRQoL evaluation consisted of the administration of the
Spanish online version of the KIDSCREEN-27 and the
EQ-5D-Youth (EQ-5D-Y). The descriptive system of the
EQ-5D-Y [6] consists of five dimensions (“mobility,” “looking
after myself,” “doing usual activities,” “having pain/discomfort,”
and “feeling worried/sad/unhappy”) with three-level Likert scale
responses (no problems, moderate problems, and serious
problems). It includes also a visual analogue scale (EQ-VAS)
on the general health status rated from 0 (worst health status)
to 100 (best health status possible). The time frame for both
dimensions and EQ-VAS is “today.” As no preference weights
were available for the EQ-5D-Y to estimate utilities [23], an
equally weighted summary score of the five dimensions was
calculated [24-26], ranging from 0 (no problem in any
dimension) to 100 (serious problems in all dimensions).
The KIDSCREEN-27 [27] contains 5 dimensions: physical
well-being (5 items), psychological well-being (7 items),
autonomy and relationships with parents (7 items), social support
and relationship with friends (4 items), and school environment
(4 items). Responses were categorized into five-option Likert
scales that assess the frequency or intensity of the attribute, with
a recall period of 1 week in most questions. Scores were
calculated following developers’ recommendations [27] for the
KIDSCREEN-27 dimensions and for the KIDSCREEN-10
index, constructed with 10 items that sufficiently represent the
longer KIDSCREEN profiles. The KIDSCREEN scores are
standardized to a mean of 50 and a SD of 10, from a reference
sample of 22,000 European children and adolescents [28].
In addition to HRQoL, children’s mental health status and family
function were assessed. The Strengths and Difficulties
Questionnaire (SDQ) [29] consists of 25 items measuring a
range of mental health symptoms including conduct problems,
hyperactivity-inattention, emotional symptoms and peer
problems, and prosocial behaviors. All items are scored on a
3-point scale (0=not true, 1=somewhat true, and 2=certainly
true). Items are summed to give a total difficulties score ranging
from 0 (no problems) to 40 (maximum problems). The Spanish
version of the SDQ has shown to be reliable and valid [30]. The
family function questionnaire [31,32] was designed to measure
the patient’s satisfaction with the support from the family
through five items: Adaptation, Partnership, Growth, Affection,
and Resolve (APGAR). These items have three response options
(from almost always to hardly ever), and the total score ranges
from 0 to 10 (low to high satisfaction).
Ethics Considerations
The study was approved by the ethics committee of participant
hospitals in accordance with national and international
guidelines (code of ethics, Helsinki Declaration) as well as
legislation on data confidentiality (Organic Law 15/1999 of
December 13 Data Protection character staff). Signed consent
to participate was requested from parents and children over 12
J Med Internet Res 2019 | vol. 21 | iss. 11 | e14947 | p. 3http://www.jmir.org/2019/11/e14947/
(page number not for citation purposes)
Mayoral et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
years. The collection and transfer of data were carried out
according to strict security and data encryption.
Analytical Strategy
Considering the 136 patients included in the T1DM clinical
trial, this sample size gave a statistical power of 0.80 to detect
a moderate-to-large difference of 0.65 SDs in the EQ-5D-Y
summary score between unequally distributed known groups
(80% and 20% of participants in each category) using a
two-sided test with type I error of 5%. Statistical power was
calculated using published formulas [33].
Characteristics of the sample were described by calculating
percentages, or means and SDs, according to the type of
variable. To evaluate the acceptability of the EQ-5D-Y, we
calculated the completion rate and the distribution of the
response options in each dimension. Distribution of the
EQ-5D-Y summary score, EQ-VAS, and the KIDSCREEN-10
index was described by calculating the observed range, floor,
and ceiling effects (proportion of participants with the worst
and best possible score, respectively) and statistics of central
tendency and dispersion.
Construct validity was assessed by applying two different
approaches: (1) comparison of known groups and (2) the
multitrait, multimethod matrix with data from the first visit.
Known groups were defined according to the general health
(through a question from KIDSCREEN-27), dichotomized as
excellent/very good and good/regular/bad; acute diabetic
decompensations during the previous 3 months; mental health,
dichotomized by the total SDQ score cutoff of 15; and family,
classified as dysfunctional (total APGAR score≤6) or functional
(total APGAR score=7-10) [32]. To assess differences between
known groups, a Chi-square test was used for proportions of
participants with problems, Wilcoxon nonparametric test was
used for the EQ-5D-Y summary score and EQ-VAS, and
unpaired t-test was used for KIDSCREEN scores. The
magnitude of the differences between groups was assessed by
the Cohen effect size (difference of mean/pooled SD) [34].
General guidelines define an effect size of 0.2 as small, 0.5 as
moderate, and 0.8 as large [35]. The hypotheses raised a priori,
based on available evidence, were higher EQ-5D-Y summary
score (worse HRQoL) in children reporting worse general health
[11], with previous acute diabetic decompensations [36,37],
worse mental health [11,38], and with a dysfunctional family
[39,40].
The multitrait, multimethod matrix between the EQ-5D-Y and
the KIDSCREEN was constructed using Spearman correlations.
The logical relationship between two instruments can be
categorized as convergent and discriminant. For the convergent
validity [7] (different instruments measuring a similar concept),
we hypothesized substantial correlations between “mobility”
(EQ-5D-Y) and “physical well-being” (KIDSCREEN-27),
“feeling worried/sad/unhappy” (EQ-5D-Y) and “psychological
wellbeing” (KIDSCREEN-27), and the KIDSCREEN-10 index
with the EQ-5D-Y summary score and EQ-VAS. In contrast,
for the discriminant validity [7] (different instruments measuring
different traits or constructs), we hypothesized low correlations
between the EQ-5D-Y dimension of “looking after myself” and
the following three KIDSCREEN-27 dimensions: “autonomy
and relationships with parents,” “social support and relationship
with friends,” and “school environment.” The strength of
Spearman correlations was defined [41] as insignificant (≤0.30),
moderate (0.31-0.44), or substantial (0.45-0.60).
The reliability was assessed in terms of reproducibility (stability
of an instrument over time) in a subsample of stable
participants—those in the control group with an absolute change
<4.5 points in the KIDSCREEN-10 index from the first to the
fourth visit, which corresponds to a small magnitude of change
(effect size<0.45). To measure the agreement in EQ-5D-Y
summary score and EQ-VAS between both administrations, the
intraclass correlation coefficient (ICC) was calculated. To assess
responsiveness, we classified participants experiencing
“improvement” as those with a change in KIDSCREEN-10
index ≥4.5 points (moderate effect size) between the first and
the fourth visits. Differences for the EQ-5D-Y dimensions were
compared using the McNemar paired test, while differences
between the EQ-5D-Y summary score and EQ-VAS were tested
with the Wilcoxon paired test. The magnitude of change was
also measured by the effect size coefficient (mean of change/SD
of change). Program STATA.14 software (StateCorp LP,
College Station, Texas) was used in the analysis.
Results
Sample Characteristics
Of 205 potential candidates with T1DM, 61 were not included
due to change of address, transfer to the adult unit, or no
attendance at the follow-up visits; in addition, 8 subjects rejected
participation. Finally, 136 participants were included in the
study. Table 1 shows the characteristics of the sample. Mean
age was 14 years, around half of the participants were girls, 71
(52.2%) had HbA1c levels ≤7.5% (58 mmol/mL), 123 (90.4%)
did not present acute diabetic decompensations during the
previous 3 months, and the majority (n=95) rated their health
as good or very good.
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Table 1. Demographic and clinical characteristics of the participants (N=136).
ValueCharacteristic
13.99 (0.2)Age (years)a, mean (SD)
45 (33.3)8-12, n (%)
54 (40.0)13-15, n (%)
35 (25.9)16-18, n (%)
1 (0.7)>18, n (%)
Sex, n (%)
72 (52.9)Girls
64 (47.1)Boys
7.7 (1.3)Metabolic control, HbA1cb, mean (SD)
65 (47.8)>7.5, n (%)
71 (52.2)≤7.5, n (%)
Acute diabetic decompensations (previous 3 months), n (%)
13 (9.6)Yes
123 (90.4)No
General Health Question (KIDSCREEN-27), n (%)
19 (13.9)Excellent
44 (32.4)Very good
54 (39.7)Good
17 (12.5)Regular
2 (1.5)Bad
10.64 (5.3)Mental health (total SDQc score), mean (SD)
113 (83.1)0-15, n (%)
23 (16.9)16-40, n (%)
Family function (APGARd), n (%)
52 (38.2)Dysfunctional
84 (61.8)Functional
aThe age of one participant is missing (N=135).
bHbA1c: glycated hemoglobin.
cSDQ: Strengths and Difficulties Questionnaire.
dAPGAR: Adaptation, Partnership, Growth, Affection, and Resolve.
Distribution of Dimensions and Indices of
Health-Related Quality of Life
Children and adolescents with T1DM reported relatively fewer
health problems in the EQ-5D-Y dimensions (Table 2),
especially for “mobility” (n=3, 2.2%) and “looking after myself”
(n=4, 2.9%). Dimensions showing higher percentages of
participants with problems were “having pain or discomfort”
(n=47, 34.6%) and “feeling worried/sad/unhappy” (n=39,
28.6%). Means and 95% CI of KIDSCREEN-27 dimensions
(Table 3) were below 50 (European sample mean [28]) for
“physical well-being” (46.2, 95% CI 44.7-47.7) and over 50 for
“school environment” (52.0, 95% CI 50.4-53.6) and “social
support/relationship with friends” (53.6, 95% CI 52.1-55.1). As
shown in Table 4, the mean (SD) of the EQ-5D-Y summary
score was 8.5 (10.9), with ceiling and floor effects of 50.7%
and 0%, respectively. The EQ-VAS ranged in our sample from
31 to 100, with a mean (SD) of 80.4 (14.7). The KIDSCREEN
index ranged from 40.0 to 83.8, and the mean (SD) was 49.7
(8.3).
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Table 2. Distribution of the EuroQol-5D-Youth (EQ-5D-Y) dimensions.
A lot of problems, n (%)Some problems, n (%)No problems, n (%)EQ-5D-Y dimensions
0 (0.0)3 (2.2)133 (97.8)Mobility
0 (0.0)4 (2.9)132 (97.1)Looking after myself
0 (0.0)17 (12.5)119 (87.5)Doing usual activities
2 (1.5)45 (33.1)89 (65.4)Having pain/discomfort
4 (2.9)35 (25.7)97 (71.3)Feeling worried/sad/unhappy
Table 3. Distribution of KIDSCREEN-27 dimensions.
MedianMean (SD), 95% CIKIDSCREEN-27 dimensions
44.746.2 (9.0), 44.7-47.7Physical well-being
49.550.5 (8.2), 49.1-51.9Autonomy/relationships with parents
51.152.0 (9.3), 50.4-53.6School environment
53.353.6 (9.1), 52.1-55.1Social support and relationship with friends
48.549.7 (9.7), 48.1-51.3Psychological well-being
Table 4. Distribution of the EuroQol-5D-Youth (EQ-5D-Y) summary score, EuroQol-Visual Analog Scale (EQ-VAS), and KIDSCREEN-10 index.
KIDSCREEN-10 indexEQ-VASEQ-5D-Y summary scoreDistribution of scores
–3.54 to 83,810-1000-100Theoretical range
40.0-83.8131-1000-40Observed range
0.78.150.7Proportion of participants with the best health (%)
000Proportion of participants with the worst health (%)
49.7 (8.3)80.4 (14.7)8.5 (10.9)Mean (SD)
Construct Validity of the EuroQol-5D-Youth Online
Table 5 shows statistically significant HRQoL differences
between groups defined by their general health in three of five
EQ-5D-Y dimensions as well as EQ-5D-Y summary score,
EQ-VAS, and KIDSCREEN-10 index (P<.001, P<.001, and
P=.02, respectively) with moderate-large effect sizes (0.7, 1.0,
and 0.6, respectively). Similar significant HRQoL differences
were found according to mental health with large effect sizes,
except for the EQ-VAS. The only significant difference between
those with and without acute diabetic decompensations was
found in the “looking after myself” dimension (P=.005). Finally,
HRQoL differences between functional and dysfunctional
families were statistically significant for the “having pain and
discomfort” EQ-5D-Y dimension (P=.03) and KIDSCREEN-10
index (P<.001).
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Table 5. Comparison of health-related quality of life between known groups measured at baseline.
KIDSCREEN-10
index, mean (SD),
median
EQ-VASb, mean
(SD), median
EQ-5D-Y summary
score, mean (SD),
median
EQ-5D-Ya dimensionsVariables
W/S/UgHP/DfDUAeLAMdMc
General health question
52.24 (6.9), 53.187.6 (10.5), 905.08 (8.4), 019.1%22.2%4.8%3.2%0.0%Excellent/very good
47.47 (8.9), 45.774.1 (15.0), 7511.51 (12.1), 1037.0%45.2%19.2%2.7%4.1%Good/regular/bad
.02h<.001h<.001h.02h<.01h.02h1.00.25P value
0.6 (0.25-0.94)1.0 (0.66-1.38)0.7 (0.39-1.09)N/AN/AN/AN/AN/AiEffect size (95% CI)
Acute diabetic decompensations
50.21 (9.8), 46.974.9 (18.0), 7513.85 (13.2), 10.046.2%38.5%23.1%15.4%7.7%Yes
49.63 (8.2), 48.380.9 (14.3), 817.97 (10.6), 026.8%34.2%11.4%1.6%1.6%No
.81.21.08.14.76.23
.005h.26P value
0.07 (–0.5 to 0.65)0.4 (–0.17 to 0.99)0.5 (–0.04 to 1.12)N/AN/AN/AN/AN/AEffect size (95% CI)
Mental health (SDQj)
50.84 (8.3), 49.881.3 (14.8), 816.11 (8.4), 020.4%28.3%8.9%2.7%0.9%Score 0-15
44.01 (5.6), 43.475.7 (13.5), 7520.43 (14.3), 2069.6%65.2%30.4%4.4%8.7%Score 16-40
<.001h.06<.001h<.001h.001h.004h.53.07P value
0.9 (0.40-1.32)0.4 (–0.07 to 0.83)1.5 (1.01-1.98)N/AN/AN/AN/AN/AEffect size (95% CI)
Family function (APGAR k )
51.46 (8.6), 50.681.6 (15.1), 857.02 (9.9), 025.0%27.4%10.7%4.8%1.2%Score≤6
46.81 (6.9), 46.978.3 (13.9), 8010.96 (12.3), 1034.6%46.2%15.4%0.0%3.9%Score 7-10
<.001h.12.06.23.03h.42.30.56P value
0.6 (0.22-0.93)0.2 (–0.12 to 0.58)0.4 (0.01-0.71)N/AN/AN/AN/AN/AEffect size (95% CI)
aEQ-5D-Y: EuroQol-5D-Youth.
bEQ-VAS: EuroQol-Visual Analog Scale.
cM: mobility.
dLAM: looking after myself.
eDUA: doing usual activities.
fHP/D: having pain/discomfort.
gW/S/U: feeling worried/sad/unhappy.
hStatistically significant difference.
iN/A: not applicable.
jSDQ: Strengths and Difficulties Questionnaire.
kAPGAR: Adaptation, Partnership, Growth, Affection, and Resolve.
Table 6 presents the multitrait, multimethod matrix between
EQ-5D-Y and KIDSCREEN. Regarding convergent validity,
of the four correlations previously hypothesized as substantial,
subscript a), three obtained coefficient values of 0.45 or greater:
0.58 between EQ-5D-Y “feeling worried/sad/unhappy” and
KIDSCREEN “psychological wellbeing,” 0.50 between the
EQ-5D-Y summary score and KIDSCREEN-10 index, and 0.46
between the EQ-VAS and KIDSCREEN-10 index. In contrast,
the correlation between the mobility dimension of the EQ-5D-Y
and the physical well-being dimension of the KIDSCREEN-27
was 0.21. For discriminant validity, the three relationships
hypothesized as insignificant (subscript b) ranged from 0.02 to
0.06, as expected.
J Med Internet Res 2019 | vol. 21 | iss. 11 | e14947 | p. 7http://www.jmir.org/2019/11/e14947/
(page number not for citation purposes)
Mayoral et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
Table 6. Multitrait, multimethod matrix between the EuroQol-5D-Youth (EQ-5D-Y) and the KIDSCREEN in children and adolescents with type 1
diabetes mellitus at baseline evaluation.
KIDSCREEN-10
index
KIDSCREEN-27EQ-5D-Y
School environmentSocial support and
relationship with
friends
Autonomy and
relationships
with parents
Psychological
well-being
Physical well-
being
0.160.120.060.020.190.21aMobility
0.030.06b0.02b0.06b0.070.02Looking after myself
0.250.250.140.080.290.17Doing usual activities
0.320.170.130.230.310.27Having pain/discomfort
0.560.400.360.220.58a0.30Feeling worried/sad/unhappy
0.50a0.000.180.010.100.23EQ-5D-Y summary score
0.46a0.350.140.210.310.38EuroQol-Visual Analog Scale
aCorrelations hypothesized as substantial (0.45-0.60).
bCorrelations hypothesized as insignificant (≤0.30).
Reproducibility and Responsiveness
Table 7 shows EQ-5D-Y test-retest results in the “stable”
subsample between the first and the fourth visit. The ICC was
0.83 and 0.74 for the EQ-5D-Y summary score and EQ-VAS,
demonstrating stability over time for this subsample. Regarding
responsiveness, this “improvement” subsample presented
significant changes in three dimensions, in the EQ-5D-Y
summary score, and EQ-VAS between the first visit and the
fourth visit. The effect sizes were 0.70 and 0.74, indicating an
improvement of moderate-to-large magnitude.
Table 7. Reproducibility and responsiveness of EuroQol-5D-Youth (EQ-5D-Y): problems reported by each dimension, summary score, and EuroQol-Visual
Analog Scale (EQ-VAS) at the first and fourth visits.
Responsiveness among participants with improve-
ment (n=58)
Test-retest reproducibility among stable participants
(n=18)
EQ-5D-Y
P valueFourth visitFirst visitP valueFourth visitFirst visit
EQ-5D-Y dimensions
.631 (1.7)3 (5.2)
—
a1 (5.6)0 (0.0)Mobility, n (%)
>.991 (1.7)2 (3.5)—0 (0.0)1 (5.6)Looking after myself, n (%)
.02b2 (3.5)9 (15.5).061 (5.6)1 (5.6)Doing usual activities, n (%)
<.001b11 (18.9)27 (46.6).134 (22.2)4 (22.2)Having pain/discomfort, n (%)
<.001b10 (17.2)23 (39.7).145 (27.8)6 (33.3)Feeling worried/sad/unhappy, n (%)
<.001b.71EQ-5D-Y summary score
4.31(7.0)11.90 (12.6)6.11 (7.8)6.67 (9.1)Mean (SD)
0.70 (0.31 to 1.02)N/A0.07 (–0.61 to 0.74)N/AcEffect size (95% CI)
N/AN/A0.83 (0.55 to 0.94)N/AICCd (95% CI)
<.001b.15EQ-VAS
86.9 (13.0)76.0 (16.6)86 (9.1)82 (13.5)Mean (SD)
0.74 (0.36 to 1.12)N/A0.35 (–0.34 to 1.03)N/AEffect size (95% CI)
N/AN/A0.74 (0.31 to 0.90)N/AICC (95% CI)
aNot available.
bStatistically significant difference.
cN/A: not applicable.
dICC: intraclass correlation coefficient.
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Discussion
To the best of our knowledge, this is the first study evaluating
metric properties of the new EQ-5D-Y in T1DM children and
adolescents. We found this generic preference-based instrument
to be acceptable for children and adolescents with T1DM and
easy to administer online, but with a high ceiling effect (50.7%
of participants reported no problem in any dimension). The
EQ-5D-Y showed good validity, considering the results obtained
in the known groups’ analysis based on general health, acute
diabetic decompensations, mental health, and family function,
and those obtained from the multitrait, multimethod matrix with
KIDSCREEN. Test-retest reproducibility was high, indicating
good reliability, and the moderate-large change observed
between the first and fourth visits among the selected subsample
of “improvement” supports its responsiveness.
Of the 136 participants in the T1DM study, all responded to the
EQ-5D-Y at the first visit and 119 (87.5%) responded at the
fourth visit, which is similar to the response rates reported by
studies carried out in the clinical (96% [18]) and school (77%
[16]) settings. It is important to remark that the participants
answering the EQ-5D-Y entirely completed the instrument,
including the five dimensions, and the EQ-VAS. These rates of
completion support the acceptability of the EQ-5D-Y among
children and adolescents with T1DM when administered online.
Taking into account the quick expansion of online recreational
habits among the new generations born in the digital era,
acceptability could be even higher with the incorporation of
other devices such as apps for smartphones or tablets. However,
completion rates in routine clinical practice could be lower than
under clinical trial conditions, which indicates the need for
closer monitorization.
Ceiling effect in the sample of children and adolescents with
T1DM was high for the EQ-5D-Y summary score (50.7%) and
for the three out of its five dimensions, which exceeded 85%
of participants reporting no problem (“mobility,” “looking after
myself,” and “doing usual activities”). A European multicountry
study of EQ-5D-Y metric properties [11] reported a similar
ceiling effect for these dimensions, which was up to 80% in
children with chronic conditions. Half of the children and
adolescents with no problem in any dimension (value=0 in
EQ-5D-Y summary score) could be considered to show a really
high ceiling effect, taking into account the established
recommendations of 15% for HRQoL scores [42]. However,
this is a general standard, as there are none specific for children.
This high ceiling effect could be considered coherent with the
relative low impact of diabetes on HRQoL for most children
and adolescents, partially explained by their capacity of
adaptation to the demanding tasks related to care [43]. The main
disadvantage of this high ceiling effect is that it avoids the
detection of improvement in children and adolescents who
reported the highest level of health, which could affect the
instrument’s responsiveness.
On the other hand, our study showed a substantial proportion
of children and adolescents with T1DM reporting problems in
the dimensions of “having pain or discomfort” (n=47, 34.6%)
and “feeling worried/sad/unhappy” (n=43, 28.7%). These results
are consistent with a previous study [44] showing this latter
EQ-5D-Y dimension as the most affected in children and
adolescents with T1DM. They are also consistent with studies
using the 21-item Beck Depression Inventory and the Child
Health Questionnaire PF-50 [45,46], which highlighted the
impact of T1DM on the psychological dimension, especially
due to the lack of autonomy, worrying for future chronic
complications and the self-care routines that these children and
adolescents have to experience.
As hypothesized, the EQ-5D-Y presented a good discrimination
capacity between groups defined by the general health question
and SDQ score in the summary score and in three dimensions:
“doing usual activities,” “having pain/discomfort,” and “feeling
worried/sad/unhappy.” These dimensions presented the highest
correlations with general and mental health in previous studies
of children and adolescents with T1DM [41] or chronic
conditions [10]. The magnitude of the difference between groups
defined by these constructs was larger when HRQoL was
measured with the EQ-5D-Y summary score (effect size for
general health and mental health groups=0.7 and 1.5,
respectively) than with the KIDSCREEN-10 index (effect size
for general health and mental health groups=0.6 and 0.9,
respectively).
It is important to highlight the problems reported in the “looking
after myself” dimension among those participants who had
previously experienced acute diabetic decompensations, which
is consistent with previous studies comparing good and bad
metabolic control [37,47]. These participants showed differences
in the physical well-being and health perception dimensions,
measured with KINDL-R [37] and the Diabetes Quality of Life
questionnaire [42]. A priori hypotheses on the relationship
between family function and HRQoL were based on studies
that reported an increased risk for depressive symptoms in
families with a disadvantaged socioeconomic status [39,48].
Our results, showing problems of “having pain and discomfort”
more frequently and poorer HRQoL with KIDSCREEN-10
index in children and adolescents with dysfunctional families,
are in line with the social component of health [39,48].
Correlations between EQ-5D-Y and KIDSCREEN showed the
expected pattern for convergent and divergent validity, which
were very similar to those obtained in the abovementioned
European multicountry study [11]. The dimensions reflecting
the emotional aspects of EQ-5D-Y (“feeling
worried/sad/unhappy”) and KIDSCREEN-27 (“psychological
well-being”), in addition to the EQ-5D-Y summary score and
EQ-VAS, presented a substantial correlation with the
KIDSCREEN-10 index, which provides a summary of the
HRQoL. The EQ-5D-Y “mobility” dimension failed to display
convergent validity with the KIDSCREEN dimension “physical
wellbeing,” similar to a previous study [11] (r=0.10-0.25).
Considering the content of the instruments, it can be argued that
KIDSCREEN is more focused on the energy level and less
focused on the physical functioning, which is the case of the
EQ-5D-Y.
Our study shows good reproducibility of the questionnaire
according to the established standards [7] for reliability
coefficients: 0.7 and 0.9 for group and individual measurements,
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respectively. The ICC of 0.83 and 0.74 obtained for the
EQ-5D-Y summary score and EQ-VAS allows recommending
its use. Nine months between the first and the fourth visit is too
long a period to evaluate reproducibility, since HRQoL could
change considerably during this time. This long period explains
the low number of children and adolescents in the stable
subsample (n=18). Previous EQ-5D-Y studies used the kappa
coefficient to evaluate test-retest reporting from good to fair
agreement, according to dimensions [11,15].
The EQ-5D-Y detected differences in the selected subsample
of children and adolescents with T1DM classified as
experiencing “improvement” between the first and the fourth
visit, showing the capacity of this instrument to detect change.
It is important to highlight that no other studies testing the
responsiveness of the EQ-5D-Y have been found. A systematic
review assessing metric properties of diabetes-specific HRQoL
instruments also highlighted that the lack of testing for
responsiveness is a major shortcoming [49]. The EQ-5D-Y
summary score indicates a moderate-large improvement over
time, a magnitude which can be considered reasonable when
accounting for the length of the follow-up of participants (9
months), the nature of the intervention, and the course of the
T1DM.
The T1DM clinical trial provides a comprehensive and complete
database of EQ-5D-Y and disease-related variables to allow
assessment of metric properties including validity, reliability,
and responsiveness. However, some limitations need to be
addressed. First, the assessment of the acceptability is not
complete: Other indicators such as administration time needed
to complete the questionnaire and patient views about the
instrument should be included in further studies. Second, since
the EuroQol group has not developed the value set for the
EQ-5D-Y yet [23], the unweighted summary score was
calculated as was done in previous studies [24-26]. However,
this summary score did not allow cost-utility analysis. Third,
the EQ-5D-Y does not cover social dimension, a key aspect of
children’s HRQoL, but it presents an acceptable capacity of
discrimination between functional and dysfunctional families
in our study. There are other generic pediatric instruments that
cover social dimensions, such as KIDSCREEN [50] (“autonomy
and relationships with parents,” “social support,” “relationship
with friends,” and “school environment”), PedsQol [51] (“social
functioning” and “school functioning”), or the Child Health
Questionnaire [52] (“role/social emotional and behavioral
functioning”). Fourth, this is a secondary analysis of a study
designed for purposes other than the evaluation of the metric
properties of EQ-5D-Y. For example, as commented above, the
9-month period between test and retest is too long for measuring
reproducibility, and no large change is expected with the
intervention applied. Furthermore, results on stability should
be interpreted with caution due to the small sample size. Finally,
regarding external validity, the results of this study should not
be generalized to other chronic conditions.
Despite the limitations discussed above, our results provide
considerable evidence supporting the appropriate metric
properties of the EQ-5D-Y in patients with T1DM. In
conclusion, these findings suggest that the EQ-5D-Y
administered online is an acceptable, valid, reliable, and
responsive instrument for evaluating HRQoL in children and
adolescents with this chronic condition. Since it is a
preference-based health status measure, it will allow calculating
quality-adjusted life-years (combining both the quantity and
quality of life) for economic evaluations, once social preferences
specifically for children become available. Given its short and
easy administration, the EQ-5D-Y is a practical instrument to
implement in primary care to routine monitoring. It is a
promising instrument to compare the efficiency of different
programs or treatment strategies, helping prioritize and invest
at different levels.
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